You are here

P&T News

February 17

Committee sees “virtually no chance” of a positive effect
Drug surged in summer of 2016, causing hundreds of overdose deaths
Researchers utilize gene activity signatures to identify candidates
Annualized relapse rate reduced compared with interferon beta-1a

February 16

New rule seeks to prevent enrollees from “gaming the system”
Is common steroid worth the price?
Siliq binds to pro-inflammatory protein
Inhalation spray now approved for age 6 and older

February 15

Insurance coverage hinges on solid efficacy data
Company’s move may herald things to come
STAT investigation finds many promises but few results
Data show noninferiority to darunavir

February 14

Generic steroid has been around for decades
“We can and must do better,” new article’s authors say
Patients could save up to $7,500 per month with new regimen
Hospital group warns of financial crisis from stand-alone repeal
Clinical trials are needed to reveal safety risks